Literature DB >> 19588039

Ensuring access to psychotropic medication in sub-Saharan Africa.

J Eaton1.   

Abstract

In this review article, the issues related to provision of psychotropic drugs in services in sub-Saharan Africa are explored. Problems encountered in procurement of drugs, their safe prescription and practical supply systems are discussed, with possible solutions suggested. The evidence-base for the preferential use of first-generation drugs is presented, with the practical implications for cost-effective service delivery shown. Options for sourcing of quality drugs are outlined with practical examples. An argument is made for a wider range of medical personnel to be allowed to prescribe than is often currently the case. This is so as to allow for the scale up of community based psychiatric services which will otherwise fail to meet the needs of the majority of persons with mental illnesses, particularly in rural communities. Drug Revolving Funds are proposed as a means of managing supplies by local projects in a context of a lack of an alternative supply. Some suggestions are made for practical solutions to the problem of those cannot afford even cheaper medications.

Entities:  

Year:  2008        PMID: 19588039     DOI: 10.4314/ajpsy.v11i3.30227

Source DB:  PubMed          Journal:  Afr J Psychiatry (Johannesbg)


  11 in total

1.  Adherence to generic v. brand antidepressant treatment and the key role of health system factors.

Authors:  C Barbui; V Conti
Journal:  Epidemiol Psychiatr Sci       Date:  2014-12-18       Impact factor: 6.892

2.  Access and use of psychotropic medicines in low-resource settings.

Authors:  C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2015-03-19       Impact factor: 6.892

3.  Mapping actions to improve access to medicines for mental disorders in low and middle income countries.

Authors:  C Barbui; T Dua; K Kolappa; B Saraceno; S Saxena
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-09       Impact factor: 6.892

4.  Community mental health care worldwide: current status and further developments.

Authors:  Graham Thornicroft; Tanya Deb; Claire Henderson
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

5.  Access and rational use of psychotropic medications in low- and middle-income countries.

Authors:  P Padmanathan; D Rai
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-21       Impact factor: 6.892

6.  Three models of community mental health services In low-income countries.

Authors:  Alex Cohen; Julian Eaton; Birgit Radtke; Christina George; Bro Victor Manuel; Mary De Silva; Vikram Patel
Journal:  Int J Ment Health Syst       Date:  2011-01-25

7.  Psychotropic drugs in Nepal: perceptions on use and supply chain management.

Authors:  Nawaraj Upadhaya; Mark J D Jordans; Dristy Gurung; Ruja Pokhrel; Ramesh P Adhikari; Ivan H Komproe
Journal:  Global Health       Date:  2018-01-24       Impact factor: 4.185

8.  Mental health treatment in Kenya: task-sharing challenges and opportunities among informal health providers.

Authors:  Christine W Musyimi; Victoria N Mutiso; David M Ndetei; Isabel Unanue; Dhru Desai; Sita G Patel; Abednego M Musau; David C Henderson; Erick S Nandoya; Joske Bunders
Journal:  Int J Ment Health Syst       Date:  2017-08-01

9.  Medication challenges for patients with severe mental illness: experience and views of patients, caregivers and mental health care workers in Dar es Salaam, Tanzania.

Authors:  Masunga K Iseselo; Joel Seme Ambikile
Journal:  Int J Ment Health Syst       Date:  2017-02-06

10.  Engaging and staying engaged: a phenomenological study of barriers to equitable access to mental healthcare for people with severe mental disorders in a rural African setting.

Authors:  Maji Hailemariam; Abebaw Fekadu; Martin Prince; Charlotte Hanlon
Journal:  Int J Equity Health       Date:  2017-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.